FindTrial
Sign In

Comparing the efficiency of two coated dental Implants in controlled diabetic and non diabetic patients

Comparative Evaluation of Implant Surface Coatings on Osseointegration and Implant Stability in Controlled Diabetic and Non-Diabetic Patients: A Randomized Controlled Clinical Trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107149
Enrollment
40
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Placement of Calcium titanate-coated dental implants: Calcium titanate (Ca-Ti) coated dental implants are bioactive, superhydrophilic implants designed to enhance early osseointegration

Sponsors

Dr. DIVYA DARSINI S
Lead Sponsor
Dr U ARUNMOZHI
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Edentulous site in Maxillary or Mandibular region (D2 Bone) Patients with adequate interdental and interarch space for prosthetic rehabilitation Patients diagnosed with controlled Type 2 Diabetes Mellitus (HbA1c lessthan or equal to 7 and non-diabetic patients. Patients with good oral hygiene and motivation Patients willing to participate and provide informed consent Patients with baseline Vitamin D3

Exclusion criteria

Exclusion criteria: Patients with uncontrolled diabetes Smokers and tobacco users Patients with active periodontal disease Patients with systemic conditions affecting bone healing (e.g osteoporosis, immunocompromised states) Patients with a history of radiotherapy in the head and neck region Patients on bisphosphonate therapy or long-term steroid use Pregnant and lactating women Patients with poor oral hygiene or non-compliance Patients with insufficient bone volume requiring advanced augmentation procedures

Design outcomes

Primary

MeasureTime frame
To determine which implant system provides superior implant stability and osseointegration in controlled Type 2 diabetic patients.Timepoint: 17 months—

Secondary

MeasureTime frame
Implant stability assessed using Insertion Torque & Implant Stability Quotient (ISQ) by Resonance Frequency Analysis.Timepoint: insertion torque at baseline ISQ value at baseline two months four months after placement of implant;Bone density evaluation using Cone Beam Computed Tomography (CBCT).Timepoint: before placement of implant & four months after placement of implant;Marginal bone level assessment using Radiovisiography (RVG).Timepoint: baseline two months four months after placement of implants—

Countries

India

Contacts

Public ContactDr DIVYA DARSINI S

Sri Venkateswara Dental College and Hospital

drarunmozhi@yahoo.co.in9840453005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026